glycine has been researched along with Leukemic Infiltration in 1 studies
Leukemic Infiltration: A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of differentiation syndrome in a patient receiving the IDH1 inhibitor ivosidenib, with skin biopsy showing isocitrate dehydrogenase (IDH) R132H-mutated leukemia cutis." | 7.96 | Differentiation syndrome during ivosidenib treatment with immunohistochemistry showing isocitrate dehydrogenase R132H mutation. ( Chase, M; Fernandez-Pol, S; Kwong, BY; Novoa, RA; Tabata, MM, 2020) |
| "We report a case of differentiation syndrome in a patient receiving the IDH1 inhibitor ivosidenib, with skin biopsy showing isocitrate dehydrogenase (IDH) R132H-mutated leukemia cutis." | 3.96 | Differentiation syndrome during ivosidenib treatment with immunohistochemistry showing isocitrate dehydrogenase R132H mutation. ( Chase, M; Fernandez-Pol, S; Kwong, BY; Novoa, RA; Tabata, MM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tabata, MM | 1 |
| Chase, M | 1 |
| Kwong, BY | 1 |
| Novoa, RA | 1 |
| Fernandez-Pol, S | 1 |
1 other study available for glycine and Leukemic Infiltration
| Article | Year |
|---|---|
Differentiation syndrome during ivosidenib treatment with immunohistochemistry showing isocitrate dehydrogenase R132H mutation.
Topics: Aged; Antineoplastic Agents; Diagnosis, Differential; Glycine; Humans; Immunohistochemistry; Isocitr | 2020 |